ANN ARBOR, Mich. -- Researchers have identified potential genetic alterations in penile cancer that could pave the way for targeted treatments.
For many patients with this rare cancer, surgery is all that's needed. But in aggressive forms of penile cancer, few therapeutic options exist, particularly targeted therapies.
The new study, led by researchers at the University of Michigan Comprehensive Cancer Center, describe a complex landscape that could suggest potential clinical trials of targeted therapies - and potential limitations in some patients.